LMR Partners’s Sanofi SNY Stock Holding History

LMR Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200,000	Closed	-$9.69M	–	1836
2025 Q4	$9.69M	Sell	200,000 -125,000	-38%	-$6.2M	0.02%	396
2025 Q3	$15.3M	Buy	+325,000	New	+$15.7M	0.07%	224

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LMR Partners's SNY Position: Q2 2024 in Review

LMR Partners sold out of Sanofi (SNY) in Q2 2024, closing a stake of 13,700 shares — an estimated $666K sold.

LMR Partners first reported a position in SNY in Q4 2019 and held it in 8 quarters. The position peaked at $5.68M in Q4 2021. 728 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

LMR Partners reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
LMR Partners sold 13,700 Sanofi shares in Q2 2024, an estimated $666K.
LMR Partners first reported a position in Sanofi in Q4 2019 and held it in 8 quarters.
LMR Partners's Sanofi position peaked at $5.68M in Q4 2021.
728 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.